63 related articles for article (PubMed ID: 22395995)
1. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
[TBL] [Abstract][Full Text] [Related]
2. Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Francis AM; Haugen CE; Grimes LM; Crow JR; Yi M; Mittendorf EA; Bedrosian I; Caudle AS; Babiera GV; Krishnamurthy S; Kuerer HM; Hunt KK
Ann Surg Oncol; 2015 Dec; 22(13):4270-9. PubMed ID: 25905585
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.
Shapiro-Wright HM; Julian TB
J Natl Cancer Inst Monogr; 2010; 2010(41):145-9. PubMed ID: 20956820
[TBL] [Abstract][Full Text] [Related]
4. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast.
Zavagno G; Carcoforo P; Marconato R; Franchini Z; Scalco G; Burelli P; Pietrarota P; Lise M; Mencarelli R; Capitanio G; Ballarin A; Pierobon ME; Marconato G; Nitti D
BMC Cancer; 2005 Mar; 5():28. PubMed ID: 15762990
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Imaging Characteristics of Contrast-enhanced Mammography and MRI to Distinguish Microinvasive Carcinoma from Ductal Carcinoma In situ.
Hua B; Yang G; An Y; Lou K; Chen J; Quan G; Yuan T
Acad Radiol; 2024 May; ():. PubMed ID: 38734581
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ.
Pang J; Yan Z; Tan QT; Allen JC; Wang M; Lim GH
Clin Breast Cancer; 2024 Feb; ():. PubMed ID: 38458843
[TBL] [Abstract][Full Text] [Related]
7. A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis.
Fujimoto M; Kobayashi Y; Kuraoka K; Yoshiyama T; Shigematu H
Surg Case Rep; 2023 Dec; 9(1):209. PubMed ID: 38036933
[TBL] [Abstract][Full Text] [Related]
8. Just medical oncology guidelines….
Pardo García R; Piñero Madrona A; Algara López M; Bernet Vegué L; Eraso Urien A
Clin Transl Oncol; 2023 Nov; 25(11):3319-3320. PubMed ID: 37438652
[No Abstract] [Full Text] [Related]
9. Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases.
Matsen CB; Hirsch A; Eaton A; Stempel M; Heerdt A; Van Zee KJ; Cody HS; Morrow M; Plitas G
Ann Surg Oncol; 2014 Oct; 21(10):3330-5. PubMed ID: 25092160
[TBL] [Abstract][Full Text] [Related]
10. Axillary node staging for microinvasive breast cancer: is it justified?
Lyons JM; Stempel M; Van Zee KJ; Cody HS
Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
[TBL] [Abstract][Full Text] [Related]
11. DCIS with Microinvasion: Is It In Situ or Invasive Disease?
Champion CD; Ren Y; Thomas SM; Fayanju OM; Rosenberger LH; Greenup RA; Menendez CS; Hwang ES; Plichta JK
Ann Surg Oncol; 2019 Oct; 26(10):3124-3132. PubMed ID: 31342393
[TBL] [Abstract][Full Text] [Related]
12. Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands.
Luiten JD; Luiten EJT; van der Sangen MJC; Vreuls W; Duijm LEM; Tjan-Heijnen VCG; Voogd AC
Breast Cancer Res Treat; 2021 May; 187(1):245-254. PubMed ID: 33385265
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer.
Ward WH; DeMora L; Handorf E; Sigurdson ER; Ross EA; Daly JM; Aggon AA; Bleicher RJ
Ann Surg Oncol; 2020 Feb; 27(2):386-396. PubMed ID: 31562602
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for lymph node metastasis and the impact of adjuvant chemotherapy on ductal carcinoma in situ with microinvasion: a population-based study.
Chen C; Huang S; Huang A; Jia Y; Wang J; Zhang Z; Mao M; Wang L; Zhou J
Onco Targets Ther; 2018; 11():9071-9080. PubMed ID: 30588019
[TBL] [Abstract][Full Text] [Related]
15. Current approach and future perspective for ductal carcinoma in situ of the breast.
Kanbayashi C; Iwata H
Jpn J Clin Oncol; 2017 Aug; 47(8):671-677. PubMed ID: 28486668
[TBL] [Abstract][Full Text] [Related]
16. Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?
Pilewskie M; Karsten M; Radosa J; Eaton A; King TA
Ann Surg Oncol; 2016 Jul; 23(7):2229-34. PubMed ID: 26960927
[TBL] [Abstract][Full Text] [Related]
17. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
Tunon-de-Lara C; Chauvet MP; Baranzelli MC; Baron M; Piquenot J; Le-Bouédec G; Penault-Llorca F; Garbay JR; Blanchot J; Mollard J; Maisongrosse V; Mathoulin-Pélissier S; MacGrogan G
Ann Surg Oncol; 2015 Nov; 22(12):3853-60. PubMed ID: 25777085
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
